FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093961711> ?p ?o ?g. }

• W2093961711 endingPage "169" @default.
• W2093961711 startingPage "163" @default.
• W2093961711 abstract "Objective: Studies of neutralizing antibodies in HIV-1 infected individuals provide insights into the quality of the response that should be possible to elicit with vaccines and ways to design effective immunogens. Some individuals make high titres of exceptional broadly reactive neutralizing antibodies that are of particular interest; however, more modest responses may be a reasonable goal for vaccines. We performed a large cross-sectional study to determine the spectrum of neutralization potency and breadth that is seen during chronic HIV-1 infection. Design: Neutralization potency and breadth were assessed with genetically and geographically diverse panels of 205 chronic HIV-1 sera and 219 Env-pseudotyped viruses representing all major genetic subtypes of HIV-1. Methods: Neutralization was measured by using Tat-regulated luciferase reporter gene expression in TZM-bl cells. Serum-neutralizing activity was compared with a diverse set of human mAbs that are widely considered to be broadly neutralizing. Results: We observed a uniform continuum of responses, with most sera displaying some level of cross-neutralization, and approximately 50% of sera neutralizing more than 50% of viruses. Titres of neutralization (potency) were highly correlated with breadth. Many sera had breadth comparable to several of the less potent broadly neutralizing human mAbs. Conclusion: These results help clarify the spectrum of serum-neutralizing activity induced by HIV-1 infection and that should be possible to elicit with vaccines. Importantly, most people appear capable of making low to moderate titres of broadly neutralizing antibodies. Additional studies of these relatively common responses might provide insights for practical and feasible vaccine designs." @default.
• W2093961711 created "2016-06-24" @default.
• W2093961711 creator A5004036928 @default.
• W2093961711 creator A5022985881 @default.
• W2093961711 creator A5059368947 @default.
• W2093961711 creator A5069835036 @default.
• W2093961711 creator A5071657202 @default.
• W2093961711 creator A5080175927 @default.
• W2093961711 date "2014-01-14" @default.
• W2093961711 modified "2023-10-05" @default.
• W2093961711 title "Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection" @default.
• W2093961711 cites W1971233211 @default.
• W2093961711 cites W1972341594 @default.
• W2093961711 cites W1974431423 @default.
• W2093961711 cites W1978398372 @default.
• W2093961711 cites W1992566288 @default.
• W2093961711 cites W1996011751 @default.
• W2093961711 cites W2009151161 @default.
• W2093961711 cites W2013330052 @default.
• W2093961711 cites W2018123062 @default.
• W2093961711 cites W2024287923 @default.
• W2093961711 cites W2029135056 @default.
• W2093961711 cites W2070086938 @default.
• W2093961711 cites W2072974935 @default.
• W2093961711 cites W2080746125 @default.
• W2093961711 cites W2083726777 @default.
• W2093961711 cites W2084310667 @default.
• W2093961711 cites W2090763940 @default.
• W2093961711 cites W2102548388 @default.
• W2093961711 cites W2103712192 @default.
• W2093961711 cites W2105903892 @default.
• W2093961711 cites W2108823547 @default.
• W2093961711 cites W2113236498 @default.
• W2093961711 cites W2113822425 @default.
• W2093961711 cites W2115951500 @default.
• W2093961711 cites W2119704168 @default.
• W2093961711 cites W2122210861 @default.
• W2093961711 cites W2122617162 @default.
• W2093961711 cites W2134803208 @default.
• W2093961711 cites W2135151522 @default.
• W2093961711 cites W2137939749 @default.
• W2093961711 cites W2146704167 @default.
• W2093961711 cites W2152440860 @default.
• W2093961711 cites W2157210912 @default.
• W2093961711 cites W2157903295 @default.
• W2093961711 cites W2160358721 @default.
• W2093961711 cites W2171536421 @default.
• W2093961711 cites W2172063653 @default.
• W2093961711 cites W4235232179 @default.
• W2093961711 doi "https://doi.org/10.1097/qad.0000000000000106" @default.
• W2093961711 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4042313" @default.
• W2093961711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24361678" @default.
• W2093961711 hasPublicationYear "2014" @default.
• W2093961711 type Work @default.
• W2093961711 sameAs 2093961711 @default.
• W2093961711 citedByCount "309" @default.
• W2093961711 countsByYear W20939617112014 @default.
• W2093961711 countsByYear W20939617112015 @default.
• W2093961711 countsByYear W20939617112016 @default.
• W2093961711 countsByYear W20939617112017 @default.
• W2093961711 countsByYear W20939617112018 @default.
• W2093961711 countsByYear W20939617112019 @default.
• W2093961711 countsByYear W20939617112020 @default.
• W2093961711 countsByYear W20939617112021 @default.
• W2093961711 countsByYear W20939617112022 @default.
• W2093961711 countsByYear W20939617112023 @default.
• W2093961711 crossrefType "journal-article" @default.
• W2093961711 hasAuthorship W2093961711A5004036928 @default.
• W2093961711 hasAuthorship W2093961711A5022985881 @default.
• W2093961711 hasAuthorship W2093961711A5059368947 @default.
• W2093961711 hasAuthorship W2093961711A5069835036 @default.
• W2093961711 hasAuthorship W2093961711A5071657202 @default.
• W2093961711 hasAuthorship W2093961711A5080175927 @default.
• W2093961711 hasBestOaLocation W20939617111 @default.
• W2093961711 hasConcept C14086860 @default.
• W2093961711 hasConcept C159047783 @default.
• W2093961711 hasConcept C159654299 @default.
• W2093961711 hasConcept C202751555 @default.
• W2093961711 hasConcept C203014093 @default.
• W2093961711 hasConcept C2779261636 @default.
• W2093961711 hasConcept C54355233 @default.
• W2093961711 hasConcept C57992300 @default.
• W2093961711 hasConcept C71924100 @default.
• W2093961711 hasConcept C86803240 @default.
• W2093961711 hasConceptScore W2093961711C14086860 @default.
• W2093961711 hasConceptScore W2093961711C159047783 @default.
• W2093961711 hasConceptScore W2093961711C159654299 @default.
• W2093961711 hasConceptScore W2093961711C202751555 @default.
• W2093961711 hasConceptScore W2093961711C203014093 @default.
• W2093961711 hasConceptScore W2093961711C2779261636 @default.
• W2093961711 hasConceptScore W2093961711C54355233 @default.
• W2093961711 hasConceptScore W2093961711C57992300 @default.
• W2093961711 hasConceptScore W2093961711C71924100 @default.
• W2093961711 hasConceptScore W2093961711C86803240 @default.
• W2093961711 hasIssue "2" @default.
• W2093961711 hasLocation W20939617111 @default.
• W2093961711 hasLocation W20939617112 @default.
• W2093961711 hasLocation W20939617113 @default.

• next